Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct 22:8:38.
doi: 10.1186/1750-1326-8-38.

Blood-brain-barriers in aging and in Alzheimer's disease

Affiliations
Review

Blood-brain-barriers in aging and in Alzheimer's disease

Fernanda Marques et al. Mol Neurodegener. .

Abstract

The aging process correlates with a progressive failure in the normal cellular and organ functioning; these alterations are aggravated in Alzheimer's disease (AD). In both aging and AD there is a general decrease in the capacity of the body to eliminate toxic compounds and, simultaneously, to supply the brain with relevant growth and nutritional factors. The barriers of the brain are targets of this age related dysfunction; both the endothelial cells of the blood-brain barrier and the choroid plexus epithelial cells of the blood-cerebrospinal fluid barrier decrease their secretory capacity towards the brain and their ability to remove toxic compounds from the brain. Additionally, during normal aging and in AD, the permeability of the brain barriers increase. As such, a greater contact of the brain parenchyma with the blood content alters the highly controlled neural environment, which impacts on neural function. Of interest, the brain barriers are more than mere obstacles to the passage of molecules and cells, and therefore active players in brain homeostasis, which is still to be further recognized and investigated in the context of health and disease. Herein, we provide a review on how the brain barriers change during aging and in AD and how these processes impact on brain function.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Neurovascular unit composition, function and alterations in aging and in AD. (A) The BBB is formed by the tight junctions that connect the endothelial cells of the brain capillaries. These are surrounded by a basal lamina, pericytes and by astrocytes end-feets, and may as well interact directly or indirectly with neurons. (B) The endothelial cells of the BBB contain in the luminal and abluminal sides transporters and receptors. (C) Several alterations are observed at the endothelial cells of the BBB during aging and in AD.
Figure 2
Figure 2
BCSFB composition, function and alterations in aging and AD. (A) The CP is formed by a monolayer of epithelial cells originating in the ependymal cells that line the brain ventricles, forming a closed structure – the stroma. (B) CP produces CSF. CP epithelial cells contain transporters and receptors in both the basolateral and apical sides. (C) Several alterations are observed at the epithelial cells of the BCSFBB during aging and in AD.

References

    1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;8:186–191. - PubMed
    1. Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev. 2001;8:741–766. - PubMed
    1. Sotiropoulos I, Catania C, Pinto LG, Silva R, Pollerberg GE, Takashima A, Sousa N, Almeida OF. Stress acts cumulatively to precipitate Alzheimer’s disease-like tau pathology and cognitive deficits. J Neurosci. 2011;8:7840–7847. - PMC - PubMed
    1. Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, Cesari M, Nourhashemi F. Proinflammatory Cytokines, Aging, and Age-Related Diseases. J Am Med Dir Assoc. 2013;8(13):00280–00286. - PubMed
    1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood–brain barrier. Neurobiol Dis. 2010;8:13–25. - PubMed